Development and Evaluation of a Digital Educational Intervention to Improve Vaccine Confidence and Communication Among Registered Nurses: Protocol for a Randomized Controlled Trial (VaxNurse-RCT). (VaxNurse-RCT)
Nurses play an important role in providing vaccine information and supporting informed vaccination decisions.
This study will evaluate a digital educational intervention designed for registered nurses in Quebec. The intervention will provide education about vaccination, including immunology, epidemiology, vaccine communication, motivational interviewing, and responding to vaccine misinformation.
Registered nurses will be randomly assigned to either the intervention group or a control group. The study will examine whether the intervention improves vaccine confidence and vaccine communication compared with the control group.
Participants will complete questionnaires before and after the intervention, with follow-up assessments at 3 and 6 months. The study will assess vaccine hesitancy and changes in vaccine-related knowledge, communication skills, and vaccination recommendation practices.
The findings will help determine whether a digital educational intervention can support nurses in their vaccine-related communication and professional practice.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Vaccine hesitancy can influence vaccine acceptance and communication between healthcare professionals and the public. Registered nurses have an important role in vaccination, including providing information, addressing concerns, and recommending vaccination.
This study will evaluate a digital educational intervention designed to strengthen knowledge related to vaccines, confidence, and communication among registered nurses in Quebec. The intervention will complement existing immunization training of INSPQ. It will integrate content on immunology, epidemiology, motivational interviewing, vaccine communication, and responses to vaccine misinformation.
The study will use a randomized controlled design with two parallel groups. Participants will be randomly assigned to the digital educational intervention + immunization training of INSPQ or the control condition (the immunization training of INSPQ, only). The intervention will be evaluated using measurements collected before and after the intervention and during follow-up (3 months and 6 months).
The primary focus will be the effect of the intervention on vaccine hesitancy of nurses. Secondary aims will include vaccine recommendation practices, immunological and epidemiological knowledge, and vaccine communication competencies.
Questionnaires will also examine psychosocial determinants of vaccination attitudes and behaviors. The pilot phase preceding the randomized trial will support refinement of the intervention, questionnaires, study procedures, and measurement instruments.
The study aims to generate evidence on whether digital education can strengthen nurses' vaccine-related competencies and support their communication with patients and the public.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Saint-Jérôme, Canada, J7Z 0B7
- Université du Québec en Outaouais
-
Ledende efterforsker:
- Philippe Corsenac, Ph.D.
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Registered nurse authorized to practice in Quebec.
- Aged 18 years or older.
- Able to provide informed consent.
- Able to complete the study questionnaires in French or English and digital educational intervention in French.
Exclusion Criteria:
- Not currently authorized to practice as a registered nurse in Quebec.
- Unable to provide informed consent.
- Previous participation in the VaxNurse pilot study.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Digital educational intervention + immunization training of INSPQ
Registered nurses assigned to this arm will receive the digital educational intervention in addition to the existing immunization training provided by the INSPQ. The digital intervention will include immunology, epidemiology, motivational interviewing, vaccine communication, and strategies for responding to vaccine misinformation. |
The VaxNurse digital educational intervention is designed for registered nurses. It includes educational content on immunology and epidemiology, motivational interviewing, vaccine communication, and strategies for responding to vaccine misinformation. The intervention aims to reduce vaccine hesitancy and strengthen knowledge related to vaccine, confidence, communication skills, and recommendation practices. It complements existing immunization training provided by the INSPQ. |
|
Eksperimentel: Control
Registered nurses assigned to this arm will receive the existing immunization training provided by the INSPQ without the additional digital educational intervention. |
The VaxNurse digital educational intervention is designed for registered nurses. It includes educational content on immunology and epidemiology, motivational interviewing, vaccine communication, and strategies for responding to vaccine misinformation. The intervention aims to reduce vaccine hesitancy and strengthen knowledge related to vaccine, confidence, communication skills, and recommendation practices. It complements existing immunization training provided by the INSPQ. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
the Vaccine Hesitancy Scale (VHS)
Tidsramme: Baseline (T0), immediately post-intervention (Ti), 3 months, and 6 months
|
Vaccine hesitancy will be assessed using the Vaccine Hesitancy Scale (VHS). The total score ranges from 10 to 50, with higher scores indicating greater vaccine hesitancy. Change from baseline will be compared between the intervention and control groups across follow-up assessments. |
Baseline (T0), immediately post-intervention (Ti), 3 months, and 6 months
|
Samarbejdspartnere og efterforskere
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Philippe Corsenac, Ph.D., Université du Québec en Outaouais
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- CDC-453
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .